Anti-proliferative IC50 assays were also conducted using a panel of cancer cell lines with varying levels of endogenous AKR1C3 expression in the presence or absence of the AKR1C3 selective inhibitor SN34037 [43,44] (Figure 3D). Here, AKR1C3 is linked to cancer.